Results 1 to 10 of about 326,807 (261)

Editorial: Immunity and pulmonary vascular diseases: challenges, advances and future perspectives [PDF]

Frontiers in Immunology
, Zhou Daxin, Kosanovic Djuro
exaly   +2 more sources

Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases [PDF]

Biomedicines, 2020
Myeong-Sok Lee, Jongmin Kim, Kyung Hyun Yoo   +2 more
exaly   +2 more sources

Infection and pulmonary vascular diseases consortium: United against a global health challenge [PDF]

Pulmonary Circulation
Brian Graham, Oliveira Sd
exaly   +2 more sources

The original and two new derivative versions of the COMPERA 2.0 risk assessment model: useful tools for guiding balloon pulmonary angioplasty

Respiratory Research, 2022
Background The COMPERA 2.0 4-stratum (4-S) risk score has been demonstrated superior over the 3-stratum (3-S) one in patients with pulmonary arterial hypertension and medically managed patients with chronic thromboembolic pulmonary hypertension (CTEPH ...
Yi Zhang, Xin Li, Qi Jin, Qin Luo, Qing Zhao, Tao Yang, Qixian Zeng, Lu Yan, Anqi Duan, Zhihua Huang, Meixi Hu, Changming Xiong, Zhihui Zhao, Zhihong Liu   +13 more
doaj   +1 more source

A Review of Transcriptome Analysis in Pulmonary Vascular Diseases [PDF]

Methods in Molecular Biology, 2018
Roberto F Machado, Dustin Fraidenburg, Fraidenburg Dustin R   +2 more
exaly   +2 more sources

Pulmonary artery dilatation in different causes of pulmonary hypertension

Pulmonary Circulation, 2023
Pulmonary artery (PA) dilatation is commonly observed in patients with pulmonary hypertension (PH). However, the clinical aspects of PA dilatation in various etiology of PH remain unknown.
Qunying Xi, Zhihong Liu, Changming Xiong, Qin Luo, Zhihui Zhao, Qing Zhao, Tao Yang, Qixian Zeng, Pingwei Li, Luwen Qiu   +9 more
doaj   +1 more source

A stoic and altruistic orientation towards their work: a qualitative study of healthcare professionals’ experiences of awaiting a COVID-19 test result

BMC Health Services Research, 2020
Background Extensive measures to reduce person-to-person transmission of COVID-19 are required to control the current outbreak. Special attention is directed at healthcare professionals as reducing the risk of infection in healthcare is essential.
Malene Missel, Camilla Bernild, Ilkay Dagyaran, Signe Westh Christensen, Selina Kikkenborg Berg   +4 more
doaj   +1 more source

Hypertensive Pulmonary Vascular Disease [PDF]

Circulation, 1956
Patients with pulmonary artery blood pressures that are chronically elevated to levels of the order of the systemic blood pressures, form a distinct clinicopathologic entity. This condition may complicate a ventricular septal defect, Eisenmenger's complex, patent ductus arteriosus, atrial septal defect, and mitral stenosis, and it may occur as ...
D, HEATH, W, WHITAKER
openaire   +2 more sources

Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Frontiers in Cardiovascular Medicine, 2021
Background: The hemodynamic results of balloon pulmonary angioplasty vary among patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Previous studies revealed that microvasculopathy accounted for residual pulmonary hypertension
Xin Li, Yi Zhang, Qin Luo, Qing Zhao, Qixian Zeng, Tao Yang, Qi Jin, Qi Jin, Lu Yan, Anqi Duan, Jiaran Liu, Chenhong An, Xiuping Ma, Changming Xiong, Zhihui Zhao, Zhihong Liu   +15 more
doaj   +1 more source

Diagnostic and prognostic value of ventilatory power in pulmonary hypertension

Respiratory Research, 2022
Background Ventilatory power is a novel index which could reflect both ventilation efficiency and peripheral blood flow. However, its clinical value in pulmonary hypertension (PH) is rarely discussed.
Xin Li, Yi Zhang, Qi Jin, Zhihui Zhao, Qing Zhao, Lu Yan, Anqi Duan, Zhihua Huang, Meixi Hu, Changming Xiong, Qin Luo, Zhihong Liu   +11 more
doaj   +1 more source